DFTX DEFINIUM THERAPEUTICS INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Mon 9 Nov 2026 · after market close
What 23 analyst firms say about DEFINIUM THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
22 rated views · 23 analyst/firm records · 23 firms
Radar score
- Russell 2000 · Top Picks · 6MStrong · #3 in the index94
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8073
Recent analyst activity · last 90 days
Our tracked history has 20 reports on DFTX from 14 analyst firms in the last 90 days (24 firms in the past year).
Comparing each firm's latest target with its previous one: 5 raised their price target, 4 left it unchanged and 4 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Jefferies raised its target from $30.00 (set 30 Jan 2026) to $70.00 on 16 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Christopher Chen | Buy | 15 Sep 2026 | 79.00 USD |
| Bank of America Securities | Tazeen Ahmad | Buy | 18 Aug 2026 | 75.00 USD |
| Canaccord Genuity | Sumant Kulkarni | Buy | 15 Sep 2026 | 78.00 USD |
| Cantor Fitzgerald | Pete Stavropoulos | Buy | 2 Feb 2026 | — |
| Citigroup | Unnamed analyst | Buy | 22 Jun 2026 | — |
| Evercore ISI | Gavin Clark-Gartner | Buy | 6 Jul 2026 | 65.00 USD |
| H.C. Wainwright | Patrick R. Trucchio | Buy | 14 Sep 2026 | 70.00 USD |
| Jefferies | Andrew Tsai | Buy | 16 Sep 2026 | 70.00 USD |
| Jonestrading | Justin Walsh | Buy | 13 Aug 2026 | 90.00 USD |
| JPMorgan | Unnamed analyst | Buy | 9 Oct 2026 | 84.00 USD |
| Leerink Partners | Marc Goodman | Buy | 22 Jun 2026 | Conflicting reports · excluded |
| Lifesci Capital | Francois Brisebois | Buy | 5 Jun 2026 | 63.00 USD |
| Maxim Group | Michael Okunewitch | Buy | 22 Jun 2026 | 55.00 USD |
| Needham | Ami Fadia | Buy | 14 Sep 2026 | 66.00 USD |
| Oppenheimer | Jay Olson | Buy | 14 Sep 2026 | 75.00 USD |
| Piper Sandler | David Amsellem | Buy | 7 Aug 2026 | 75.00 USD |
| RBC Capital Markets | Brian Abrahams | Buy | 19 Oct 2026 | 66.00 USD |
| Stifel | Paul Matteis | Buy | 8 Jul 2026 | 60.00 USD |
| UBS | Unnamed analyst | Buy | 15 Sep 2026 | 70.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Wells Fargo | Benjamin Burnett | Buy | 13 Aug 2026 | 72.00 USD |
| Wolfe Research | Rudy Li | Buy | 23 Jun 2026 | 55.00 USD |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:40 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.